Organization | Field Name | ID | Required |
|---|---|---|---|
KCR | AJCC TNM Post Therapy Clin (yc) T (AjccTnmPostTherapyClinT) | 33172 | Yes |
AJCC | AJCC TNM Post Therapy Clin (yc) T | Yes |
Description
Evaluates the primary tumor (T) and reflects the tumor size and/or extension of the tumor known following the completion of neoadjuvant therapy (satisfying the definition for that disease site) and before planned post-neoadjuvant therapy surgical resection.
Rationale
The CoC requires that AJCC TNM staging be used in its accredited cancer programs. The CoC requires use of the current AJCC Staging System in its accredited program cancer registries when the planned post- neoadjuvant therapy surgery has been canceled. The AJCC developed this staging system for evaluating trends in the treatment and control of cancer. This staging system is used by physicians to estimate prognosis, plan treatment, evaluate new types of therapy, analyze outcomes, design follow-up strategies, and to assess early detection results.
Codes (in addition to those published in the AJCC 8th edition Cancer Staging Manual)
| Code | Description |
|---|---|
| 88 | Not applicable, no code assigned for this case in the current AJCC Staging Manual. |
| Blank | This field is left blank if no information at all is available to code this item. |
Note: See the AJCC 8th edition Cancer Staging Manual, current edition for site-specific categories for the TNM categories and stage groups. See the CURRENT STORE manual for specifications for codes and data entry rules.
Overview
Content Tools
Activity